bioRxivMicrobiologyPreprint
Highly Multiplexed Proteomic Analysis of HCMV-Infected Dendritic Cells Reveals Global Manipulation of Adaptive Immunity and Host Restriction of Viral Replication
Lauren E. Kerr-JonesiD, Lior SodayiD, Nia Cwyfan Hughes, Xinyue WangiD, Leah Hunter, Robin AntrobusiD, Kelly L. MinersiD, Kristin LadelliD, David A. PriceiD, Ceri Alan FieldingiD, Eddie C. Y. WangiD, Michael P. WeekesiD, Richard James StantoniD
- Citations
- 1
Abstract
Human cytomegalovirus (HCMV) is a clinically significant herpesvirus and a paradigm for pathogen-mediated immune-evasion. Its broad tropism includes antigen-presenting cells such as dendritic cells (DCs), which may partly explain a unique, dramatic imprint on host immunity that occurs following lifelong carriage. Despite this breadth of infection, most studies use fibroblasts as a model. We therefore developed systems to isolate pure populations of DCs infected with wild-type HCMV, before applying quantitative temporal proteomic technologies to systematically characterise the virus:DC interaction within cells and at the cell surface. This comprehensive dataset quantifying almost 9,000 proteins throughout the infection timecourse revealed multiple DC-specific viral:host effects, including key impacts on innate, intrinsic, and adaptive immunity. These effects included observations that APOBEC3A is downregulated in infected cells and restricts HCMV infection in ex vivo DCs, delaying the progression of lytic infection, and that cell surface ICOS-Ligand was downregulated by the viral genes US16 and US20, inhibiting the induction of adaptive immunity.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways
A. Rubina, M. Patel, … E. C. Y. Wang·bioRxiv·Mar 16, 2023
- Antiviral activity of Cytomegalovirus-specific CD4+ T cells against lytically infected non-haemopoietic cells
E. Y. Lim, C. J. Houldcroft, … M. R. Wills·bioRxiv·Dec 8, 2022
- Whole Virion Proteomics of HCMV Reveals that gpUL141 is a Virion Component that Regulates Envelope Glycoprotein Composition to Protect Against Humoral Immunity
Kirsten Bentley, Evelina Statkute, … Richard James Stanton·Proceedings of the National Academy of SciencesPeer-reviewed·Sep 18, 2025
- Human cytomegalovirus UL7, miR-US5-1 and miR-UL112-3p inactivation of FOXO3a protects CD34+ hematopoietic progenitor cells from apoptosis
M. H. Hancock, L. B. Crawford, … P. Caposio·bioRxiv·Sep 28, 2020
- Human cytomegalovirus protein pUL36: a dual cell death pathway inhibitor
A. Fletcher-Etherington, L. Nobre, … M. P. Weekes·bioRxiv·Feb 3, 2020
- Unveiling immune interference: How the dendritic cell response to co-infection with Aspergillus fumigatus is modulated by human cytomegalovirus and its virokine CMVIL-10
Linda Heilig, Lydia Bussemer, … Jürgen Löffler·bioRxiv·May 15, 2025